HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Midazolam in conservative dentistry. A cross-over trial.

Abstract
In a double-blind trial, 50 patients were randomly allocated to receive up to 0.29 mg/kg diazepam (Valium 5 mg/ml) or 0.14 mg/kg of midazolam (midazolam hydrochloride 5 mg/ml) intravenously at a first session of conservative dentistry, the alternative being administered at the second session. Good operating conditions were reported under each sedative and no important physiological differences were observed. Most patients failed to return to 'street fitness' 30 minutes after either session of treatment. Previous reports of reduced incidence of venous thrombophlebitis with midazolam were not convincingly confirmed in this trial, but data quality was poor. For about half the patients, the amnesic effect was stronger following midazolam.
AuthorsR A Dixon, C Kenyon, D R Marsh, J A Thornton
JournalAnaesthesia (Anaesthesia) Vol. 41 Issue 3 Pg. 276-81 (Mar 1986) ISSN: 0003-2409 [Print] England
PMID2938518 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Hypnotics and Sedatives
  • Benzodiazepines
  • Diazepam
  • Midazolam
Topics
  • Adolescent
  • Adult
  • Anesthesia, Dental (adverse effects)
  • Benzodiazepines (adverse effects)
  • Clinical Trials as Topic
  • Dentistry, Operative
  • Diazepam (adverse effects)
  • Double-Blind Method
  • Female
  • Humans
  • Hypnotics and Sedatives (adverse effects)
  • Male
  • Midazolam
  • Middle Aged
  • Patient Acceptance of Health Care
  • Thrombophlebitis (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: